187 related articles for article (PubMed ID: 9751617)
21. Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma.
Dyrskjøt L; Zieger K; Kissow Lildal T; Reinert T; Gruselle O; Coche T; Borre M; Ørntoft TF
Br J Cancer; 2012 Jun; 107(1):116-22. PubMed ID: 22596240
[TBL] [Abstract][Full Text] [Related]
22. Limited expression of cancer-testis antigens in renal cell carcinoma patients.
Soga N; Hori Y; Yamakado K; Ikeda H; Imai N; Kageyama S; Nakase K; Yuta A; Hayashi N; Shiku H; Sugimura Y
Mol Clin Oncol; 2013 Mar; 1(2):326-330. PubMed ID: 24649170
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous expression of T-cell activating antigens in renal cell carcinoma: implications for specific immunotherapy.
Ringhoffer M; Müller CR; Schenk A; Kirsche H; Schmitt M; Greiner J; Gschwend JE
J Urol; 2004 Jun; 171(6 Pt 1):2456-60. PubMed ID: 15126875
[TBL] [Abstract][Full Text] [Related]
24. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
[TBL] [Abstract][Full Text] [Related]
25. Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.
Yin B; Zeng Y; Wang X; Liu G; Zhang M; Song Y
Int J Clin Exp Pathol; 2014; 7(7):4112-9. PubMed ID: 25120790
[TBL] [Abstract][Full Text] [Related]
26. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
Spagnoli GC; Schaefer C; Willimann TE; Kocher T; Amoroso A; Juretic A; Zuber M; Luscher U; Harder F; Heberer M
Int J Cancer; 1995 Oct; 64(5):309-15. PubMed ID: 7591302
[TBL] [Abstract][Full Text] [Related]
27. Expression of melanoma-associated antigens in melanoma cell cultures.
Urosevic M; Braun B; Willers J; Burg G; Dummer R
Exp Dermatol; 2005 Jul; 14(7):491-7. PubMed ID: 15946236
[TBL] [Abstract][Full Text] [Related]
28. A single bout of dynamic exercise enhances the expansion of MAGE-A4 and PRAME-specific cytotoxic T-cells from healthy adults.
LaVoy EC; Bollard CM; Hanley PJ; Blaney JW; O'Connor DP; Bosch JA; Simpson RJ
Exerc Immunol Rev; 2015; 21():144-53. PubMed ID: 25826370
[TBL] [Abstract][Full Text] [Related]
29. Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity.
Eichmüller S; Usener D; Thiel D; Schadendorf D
Int J Cancer; 2003 Apr; 104(4):482-7. PubMed ID: 12584747
[TBL] [Abstract][Full Text] [Related]
30. Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients.
Murer K; Urosevic M; Willers J; Selvam P; Laine E; Burg G; Dummer R
Melanoma Res; 2004 Aug; 14(4):257-62. PubMed ID: 15305155
[TBL] [Abstract][Full Text] [Related]
31. HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.
Seliger B; Rongcun Y; Atkins D; Hammers S; Huber C; Störkel S; Kiessling R
Int J Cancer; 2000 Aug; 87(3):349-59. PubMed ID: 10897039
[TBL] [Abstract][Full Text] [Related]
32. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M
J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209
[TBL] [Abstract][Full Text] [Related]
33. Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype.
Palata O; Podzimkova Hradilova N; Mysiková D; Kutna B; Mrazkova H; Lischke R; Spisek R; Adkins I
Immunol Lett; 2020 Mar; 219():46-53. PubMed ID: 31931024
[TBL] [Abstract][Full Text] [Related]
34. High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies.
Dalerba P; Ricci A; Russo V; Rigatti D; Nicotra MR; Mottolese M; Bordignon C; Natali PG; Traversari C
Int J Cancer; 1998 Jul; 77(2):200-4. PubMed ID: 9650552
[TBL] [Abstract][Full Text] [Related]
35. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
[TBL] [Abstract][Full Text] [Related]
36. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
[TBL] [Abstract][Full Text] [Related]
37. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.
Bao L; Dunham K; Lucas K
Cancer Immunol Immunother; 2011 Sep; 60(9):1299-307. PubMed ID: 21626030
[TBL] [Abstract][Full Text] [Related]
38. Expression of the SART1 tumor rejection antigen in renal cell carcinoma.
Shintaku I; Kawagoe N; Yutani S; Hoshi S; Orikasa S; Yoshizumi O; Itoh K
Urol Res; 2000 Jun; 28(3):178-84. PubMed ID: 10929426
[TBL] [Abstract][Full Text] [Related]
39. Generation of RAGE-1 and MAGE-9 peptide-specific cytotoxic T-lymphocyte lines for transfer in patients with renal cell carcinoma.
Oehlrich N; Devitt G; Linnebacher M; Schwitalle Y; Grosskinski S; Stevanovic S; Zöller M
Int J Cancer; 2005 Nov; 117(2):256-64. PubMed ID: 15900605
[TBL] [Abstract][Full Text] [Related]
40. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.
Goydos JS; Patel M; Shih W
J Surg Res; 2001 Jun; 98(2):76-80. PubMed ID: 11397121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
